Literature DB >> 4039432

Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy.

H R McDonald, H Schatz.   

Abstract

We reviewed the preoperative, postoperative, and follow-up examinations, fundus photographs, and fluorescein angiograms of 175 eyes of 134 patients with proliferative diabetic retinopathy treated with panretinal photocoagulation. Forty-four (25%) of these eyes lost two or more lines of vision by the time of the last follow-up examination. Follow-ups ranged from 3 to 48 months, with a median follow-up of 15 months. The most common cause of decreased visual acuity was chronic macular edema that had developed following laser treatment, occurring in 14 (8%) eyes. The causes of visual loss following panretinal photocoagulation are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 4039432     DOI: 10.1016/s0161-6420(85)34016-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  35 in total

1.  Photochemical injury to the foveomacula of the monkey eye following argon blue-green panretinal photocoagulation.

Authors:  L M Parver
Journal:  Trans Am Ophthalmol Soc       Date:  2000

2.  The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy.

Authors:  E C Wade; G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. A randomized study with blue-green argon and red krypton lasers.

Authors:  C Capoferri; M Bagini; A Chizzoli; A Pece; R Brancato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.

Authors:  G W Blankenship
Journal:  Trans Am Ophthalmol Soc       Date:  1987

5.  Neovascularisation associated with posterior uveitis.

Authors:  E M Graham; M R Stanford; J S Shilling; M D Sanders
Journal:  Br J Ophthalmol       Date:  1987-11       Impact factor: 4.638

6.  Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.

Authors:  Jonathan F Russell; Hasenin Al-Khersan; Yingying Shi; Nathan L Scott; John W Hinkle; Kenneth C Fan; Cancan Lyu; William J Feuer; Giovanni Gregori; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2020-03-13       Impact factor: 5.258

Review 7.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

8.  Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation.

Authors:  V Seiberth; S Schatanek; E Alexandridis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

9.  Function of the diabetic retina after panretinal argon laser coagulation.

Authors:  V Seiberth; E Alexandridis; W Feng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

10.  Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.

Authors:  Kyung Seek Choi; J K Chung; Sang Hyun Lim
Journal:  Korean J Ophthalmol       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.